Role of p38 mitogen-activated protein kinase on renal dysfunction after hemorrhagic shock in rats

Shock

Volumn 24, Issue 5, 2005, Pages 488-494

  Sato, Hiroaki ^a   Tanaka, Toshito ^a   Kasai, Kentaro ^a   Kita, Toshiro ^a   Tanaka, Noriyuki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

FR167653; Hypovolemia; IL 1 ; Inflammation; mRNA; Neutrophil; TNF

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEMORRHAGIC SHOCK; HYPOTENSION; HYPOVOLEMIA; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY INJURY; MALE; NONHUMAN; RAT;

ANIMALS; BLOOD UREA NITROGEN; BLOTTING, WESTERN; CYTOKINES; HEMORRHAGE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1; KIDNEY; KIDNEY DISEASES; MALE; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRAZOLES; PYRIDINES; RATS; RATS, WISTAR; RNA, MESSENGER; SHOCK, HEMORRHAGIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27644598145     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000176594.64626.7f     Document Type: Article

References (32)

1. Deitch EA, Rutan R, Waymack JP: Trauma, shock, and gut translocation. New Horiz. 4:289-299, 1996.
2. Yao YM, Redl H, Bahrami S, Schlag G: The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res 47:201-210, 1998.
3. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 145:1016-1022, 1992.
4. Sato H, Tanaka T, Kita T, Yamaguchi H, Tanaka N: The role of tumour necrosis factor-α in renal dysfunction following mild haemorrhage in rats. Int J Exp Pathol 85:345-353, 2004.
5. Stambe C, Atkins RC, Hill PA, Nikolic-Paterson DJ: Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis. Kidney Int 64:2121-2132, 2003.
6. Huwiler A, Ren S, Holthofer H, Pavenstadt H, Pfeilschifter J: Inflammatory cytokines upregulate nephrin expression in human embryonic kidney epithelial cells and podocytes. Biochem Biophys Res Commun 305:136-142, 2003.
7. Wada T, Furuichi K, Sakai N, Hisada Y, Kobayashi K, Mukaida N, Tomosugi N, Matsushima K. Yokoyama H: Involvement of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis. Am J Kidney Dis 38:1169-1177, 2001.
8. Sakai N, Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K, Kokubo S, Kobayashi M, Takeda S, Kida H, Kobayashi K, Mukaida N, Matsushima K, Yokoyama H: p38 MAPK phosphorylation and NF-κB activation in human crescentic glomerulonephritis. Nephrol Dial Transplant 17:998-1004, 2002.
9. Stambe C, Atkins RC, Tesch GH, Kapoun AM, Hill PA, Schreiner GF, Nikolic-Paterson DJ: Blockade of p38α MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol 14:338-351, 2003.
10. Gorog DA, Tanno M, Cao X, Bellahcene M, Bassi R, Kabir AM, Dighe K, Quinlan RA, Marber MS: Inhibition of p38 MAPK activity fails to attenuate contractile dysfunction in a mouse model of low-flow ischemia. Cardiovasc Res 61:123-131, 2004.
11. Maulik N, Yoshida T, Zu YL, Sato M, Banerjee A, Das DK: Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2. Am J Physiol 275:H1857-H1864, 1998.
12. Guo X, Gerl RE, Schrader JW: Defining the involvement of p38α MAPK in the production of anti- and proinflammatory cytokines using an SB 203580-resistant form of the kinase. J Biol Chem 278:22237-22242, 2003.
13. Donnahoo KK, Shames BD, Harken AH, Meldrum DR: Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 162:196-203, 1999.
14. Bitterman H, Reissman P, Bitterman N, Melamed Y, Cohen L: Oxygen therapy in hemorrhagic shock. Circ Shock 33:183-191, 1991.
15. Kobayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Morishita Y: p38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery 131:344-349, 2002.
16. Takahashi S, Keto Y, Fujita T, Uchiyama T, Yamamoto A: FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils. J Pharmacol Exp Ther 296:48-56, 2001.
17. Matsumoto Y, Ito Y, Hayashi I, Majima M, Ishii K, Katagiri H, Kakita A: Effect of FR167653, a novel inhibitor of tumor necrosis factor-α and interleukin-1β synthesis on lipopolysaccharide-induced hepatic microvascular dysfunction in mice. Shock 17:411-415, 2002.
18. Kita T, Yamaguchi H, Sato H, Kasai K, Tanaka T, Tanaka N: Role of p38 mitogen-activated protein kinase pathway on renal failure in the infant rat after burn injury. Shock 21:535-542, 2004.
19. 2 during hemorrhagic shock. J Appl Physiol 85:2360-2364, 1998.
20. Rana MW, Shapiro MJ, Ali MA, Chang YJ, Taylor WH: Deferoxamine and hespan complex as a resuscitative adjuvant in hemorrhagic shock rat model. Shock 17:339-342, 2002.
21. Wu X, Kentner R, Stezoski J, Kochanek PM, Jackson EK, Carlos TM, Carcillo J, Behringer W, Safar P, Tisherman SA: Intraperitoneal, but not enteric, adenosine administration improves survival after volume-controlled hemorrhagic shock in rats. Crit Care Med 29:1767-1773, 2001.
22. Abraham E, Jesmok G, Tuder R, Allbee J, Chang YH: Contribution of tumor necrosis factor-α to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation. Crit Care Med 23:1319-1326, 1995.
23. Tani T, Fujino M, Hanasawa K, Shimizu T, Endo Y, Kodama M: Bacterial translocation and tumor necrosis factor-α gene expression in experimental hemorrhagic shock. Crit Care Med 28:3705-3709, 2000.
24. Meldrum KK, Meldrum DR, Hile KL, Yerkes EB, Ayala A, Cain MP, Rink RC, Casale AJ, Kaefer MA: p38 MAPK mediates renal tubular cell TNF-α production and TNF-α-dependent apoptosis during simulated ischemia. Am J Physiol Cell Physiol 281:C563-C570, 2001.
25. Nick JA, Avdi NJ, Young SK, Lehman LA, McDonald PP, Frasch SC, Billstrom MA, Henson PM, Johnson GL, Worthen GS: Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 103:851-858, 1999.
26. Haddad JJ: The involvement of L-y-glutamyl-L-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK (p38)-dependent regulation of pro-inflammatory cytokine production. Biochem Pharmacol 63:305-320, 2002.
27. Jiang J, Bahrami S, Leichtfried G, Redl H, Ohlinger W, Schlag G: Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg 221:100-106, 1995.
28. Miller AJ, Luheshi GN, Rothwell NJ, Hopkins SJ: Local cytokine induction by LPS in the rat air pouch and its relationship to the febrile response. Am J Physiol 272:R857-R861, 1997.
29. Yamamoto N, Sakai F, Yamazaki H, Sato N, Nakahara K, Okuhara M: FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-α, ameliorates endotoxin-induced shock. Eur J Pharmacol 327:169-174, 1997.
30. Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Kobayashi K, Mukaida N, Matsushima K, Yokoyama H: A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats. J Am Soc Nephrol 11:1534-1541, 2000.
31. Nishikawa M, Myoui A, Tomita T, Takahi K, Nampei A, Yoshikawa H: Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis Rheum 48:2670-2681, 2003.
32. Kitada H, Sugitani A, Yamamoto H, Otomo N, Okabe Y, Inoue S, Nishiyama K. Morisaki T, Tanaka M: Attenuation of renal ischemia-reperfusion injury by FR167653 in dogs. Surgery 131:654-662, 2002.